Interferon therapy for chronic hepatitis B.
This article summarizes the results obtained with interferon alfa and pegylated interferon alfa, as monotherapy and in combination with lamivudine, in the treatment of chronic hepatitis B.
Asselah
Tarik
T
Service d'Hépatologie, INSERM U773, CRB3, University of Paris VII, Hôpital Beaujon, 92110 Clichy, France.
Lada
Olivier
O
Moucari
Rami
R
Martinot
Michèle
M
Boyer
Nathalie
N
Marcellin
Patrick
P
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006515:Hepatitis B virus / Q000254:growth & development*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b